NCT03273790View on ClinicalTrials.gov

A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Japan

CompletedOBSERVATIONAL
Enrollment

939

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2018

Conditions
Non-Small Cell Lung Cancer
Trial Locations (1)

1050001

Local Institution, Minato-ku

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT03273790 - A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Japan | Biotech Hunter | Biotech Hunter